Phagocytes and oxidative stress

American Journal of Medicine

Volumn 109, Issue 1, 2000, Pages 33-44

  Babior, Bernard M ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE RADICAL; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYPOCHLOROUS ACID; MYELOPEROXIDASE; NITRIC OXIDE SYNTHASE; OXIDIZING AGENT; PEROXYNITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SINGLET OXYGEN; SUPEROXIDE DISMUTASE;

ATHEROSCLEROSIS; CARCINOGENESIS; EMPHYSEMA; ENZYME ACTIVITY; HOST RESISTANCE; HUMAN; NEUTROPHIL; OXIDATIVE STRESS; PHAGOCYTE; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0034725724     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00481-2     Document Type: Article

References (109)

1. Metchnikoff E. Untersuchungen über die intracelluläre verdauung beim wirbellosen thieren. Arb Zoologischen Inst Univ Wien. 1883;5:141.
2. Baldridge C.W., Gerard R.W. The extra respiration of phagocytosis. Am J Physiol. 103:1933;235.
3. Sbarra A.J., Karnovsky M.L. The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes. J Biol Chem. 234:1959;1355-1362.
4. Iyer G.Y.N., Islam M.F., Quastel J.H. Biochemical aspects of phagocytosis. Nature. 192:1961;535-541.
5. Klebanoff S.J. A peroxidase-mediated antimicrobial system in leukocytes. J Clin Invest. 46:1967;1478.
6. Babior B.M., Kipnes R.S., Curnutte J.T. Biological defense mechanisms the production by leukocytes of superoxide, a potential bactericidal agent . J Clin Invest. 52:1973;741-744.
7. Babior B.M. NADPH oxidase an update . Blood. 93:1999;1464-1476.
8. Parkos C.A., Allen R.A., Cochrane C.G., Jesaitis A.J. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J Clin Invest. 80:1987;732-742.
9. c-src Science. 1990;248:727-730.
10. Volpp BD, Nauseef WM, Donelson JE, Moser DR, Clark RA. Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase [published erratum appears in Proc Natl Acad Sci U S A.1989;86:9563]. Proc Natl Acad Sci. 1989;86:7195-7199.
11. Volpp BD, Nauseef WM, Donelson JE, Moser DR, Clark RA. Cloning of the cDNA and functional expression of the 47-kilodalton cytosolic component of human neutrophil respiratory burst oxidase [published erratum appears in Proc Natl Acad Sci U S A.1989;86:9563]. Proc Natl Acad Sci. 1989;86:7195-7199.
12. Knaus U.G., Heyworth P.G., Evans T., Curnutte J.T., Bokoch G.M. Regulation of phagocyte oxygen radical production by the GTP-binding protein Rac 2. Science. 254:1991;1512-1515.
13. Borregaard N., Christensen L., Bjerrum O.W., Birgens H.S., Clemmensen I. Identification of a highly mobilizable subset of human neutrophil intracellular vesicles that contains tetranectin and latent alkaline phosphatase. J Clin Invest. 85:1991;408-416.
14. Heyworth P.G., Curnutte J.T., Nauseef W.M., et al. Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47-phox and cytochrome b558. J Clin Invest. 87:1991;352-356.
15. Kobayashi T., Robinson J.M., Seguchi H. Identification of intracellular sites of superoxide production in stimulated neutrophils. J Cell Sci. 111:1998;81-91.
16. Forrest CB, Forehand JR, Axtell RA, Roberts RL, Johnston RB Jr. Clinical features and current management of chronic granulomatous disease. In: Curnutte JT, ed. Hematology/Oncology Clinics of North America. Phagocytic Defects II, vol. 2. Philadelphia: WB Saunders, 1988:253-266.
17. Smith R.M., Curnutte J.T. Molecular basis of chronic granulomatous disease. Blood. 77:1991;673-686.
18. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem. 64:1995;97-112.
19. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein. J Biol Chem. 244:1969;6049-6055.
20. Nelson S.K., Wong G.H.W., McCord J.M. Leukemia inhibitory factor and tumor necrosis factor induce manganese superoxide dismutase and protect rabbit hearts from reperfusion injury. J Mol Cell Cardiol. 27:1995;223-229.
21. Ho Y.S., Dey M.S., Crapo J.D. Antioxidant enzyme expression in rat lungs during hyperoxia. Am J Physiol Lung Cell Mol Physiol. 270:1996;L810-L818.
22. 2. Proc Natl Acad Sci U S A. 95:1998;6675-6680.
23. Marletta M.A. Nitric oxide synthase aspects concerning structure and catalysis . Cell. 78:1994;927-930.
24. Murad F. Regulation of cytosolic guanylyl cyclase by nitric oxide the NO-cyclic GMP signal transduction system . Adv Pharmacol. 26:1994;19-33.
25. Hevel J.M., White K.A., Marletta M.A. Purification of the inducible murine macrophage nitric oxide synthase. J Biol Chem. 266:1991;22789-22791.
26. Weinberg J.B., Misukonis M.A., Shami P.J., et al. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS) analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages . Blood. 86:1995;1184-1195.
27. Murray H.W., Nathan C.F. Macrophage microbicidal mechanisms in vivo reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani . J Exp Med. 189:1999;741-746.
28. Hampton M.B., Kettle A.J., Winterbourn C.C. Inside the neutrophil phagosome oxidants, myeloperoxidase, and bacterial killing . Blood. 92:1998;3007-3017.
29. Furtmuller P.G., Burner U., Obinger C. Reaction of myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate. Biochemistry. 37:1998;17923-17930.
30. Fenna R., Zeng J., Davey C. Structure of the green heme in myeloperoxidase. Arch Biochem Biophys. 316:1995;653-656.
31. Kizak M., Miller C.W., Selsted M.E., Koeffler H.P. Myeloperoxidase (MPO) gene mutation in hereditary MPO deficiency. Blood. 83:1994;1935-1940.
32. Lehrer R.I., Cline M.J. Leukocyte myeloperoxidase deficiency and disseminated candidasis the role of myeloperoxidase in resistance to Candida infection . J Clin Invest. 48:1969;1478-1488.
33. Lanza F. Clinical manifestation of myeloperoxidase deficiency. J Mol Med. 76:1998;676-681.
34. Mayeno A.N., Curran A.J., Roberts R.L., Foote C.S. Eosinophils preferentially use bromide to generate halogenating agents. J Biol Chem. 264:1989;5660-5668.
35. Slungaard A., Mahoney J.R. Jr. Thiocyanate is the major substrate for eosinophil peroxidase in physiologic fluids. Implications for cytotoxicity. J Biol Chem. 266:1991;4903-4910.
36. Halliwell B., Gutteridge J.M.C. Iron and free radical reactions two aspects of antioxidant protection . Trends Biochem Sci. 11:1986;372-375.
37. Higson F.K., Kohen R., Chevion M. Iron enhancement of ascorbate toxicity. Free Radic Res Commun. 5:1988;107-115.
38. Carr A.C., Winterbourn C.C. Oxidation of neutrophil glutathione and protein thiols by myeloperoxidase-derived hypochlorous acid. Biochem J. 327:1997;275-281.
39. Thomas E.L., Jefferson M.M., Grisham M. Myeloperoxidase-catalyzed incorporation of amino acids into proteins role of hypochlorous acid and chloramines . Biochemistry. 21:1982;6299-6308.
40. Grisham M.B., Jefferson M.M., Melton D.F., Thomas E.L. Chlorination of endogenous amines by isolated neutrophils. Ammonia-dependent bactericidal, cytotoxic, and cytolytic activities of the chloramines. J Biol Chem. 259:1984;10404-10413.
41. Wright C.E., Lin T.T., Lin Y.Y., Sturman J.A., Gaull G.E. Taurine scavenges oxidized chlorine in biological systems. Prog Clin Biol Res. 179:1985;137-147.
42. Green T.R., Fellman J.H., Eicher A.L., Pratt K.L. Antioxidant role and subcellular location of hypotaurine and taurine in human neutrophils. Biochim Biophys Acta Gen Subj. 1073:1991;91-97.
43. Kettle A.J., Winterbourn C.C. Superoxide-dependent hydroxylation by myeloperoxidase. J Biol Chem. 269:1994;17146-17151.
44. Steinbeck M.J., Khan A.U., Karnovsky M.J., Hegg G.G. Intracellular singlet oxygen generation by phagocytosing neutrophils in response to particles coated with a chemical trap. J Biol Chem. 267:1992;13425-13433.
45. Kanofsky J.R., Wright J., Miles-Richardson G.E., Tauber A.I. Biochemical requirements for singlet oxygen production by purified human myeloperoxidase. J Clin Invest. 74:1984;1489-1495.
46. Pryor W.A., Squadrito G.L. The chemistry of peroxynitrite a product from the reaction of nitric oxide with superoxide . Am J Physiol Lung Cell Mol Physiol. 268:1995;L699-L722.
47. Denicola A., Freeman B.A., Trujillo M., Radi R. Peroxynitrite reaction with carbon dioxide/bicarbonate kinetics and influence on peroxynitrite-mediated oxidations . Arch Biochem Biophys. 333:1996;49-58.
48. Eiserich J.P., Cross C.E., Jones A.D., Halliwell B., van der Vliet A. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid. A novel mechanism for nitric oxide-mediated protein modification. J Biol Chem. 271:1996;19199-19208.
49. Crystal RG. Impact of cell and molecular biology on pulmonary disease. In: Isselbacher KJ, Breunwald E, Wilson, JD, et al, eds. Harrison's Principles of Internal Medicine. New York: McGraw-Hill, 1994:1148-1149.
50. Janoff A. Elastase and emphysema. current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis. 1985;132:417-433.
51. Cantin A., Crystal R.G. Oxidants, antioxidants and the pathogenesis of emphysema. Eur J Respir Dis Suppl. 139:1985;7-17.
52. Hubbard R.C., Ogushi F., Fells G.A., et al. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha-1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J Clin Invest. 80:1987;1289-1295.
53. Wewers M.D., Herzyk D.J., Gadek J.E. Comparison of smoker and nonsmoker lavage fluid for the rate of association with neutrophil elastase. Am J Respir Cell Mol Biol. 1:1989;423-429.
54. Smith S.F., Guz A., Cooke N.T., Burton G.H., Tetley T.D. Extracellular elastolytic activity in human lung lavage a comparative study between smokers and non-smokers . Clin Sci. 69:1985;17-27.
55. Janoff A., Carp H., Laurent P., Raju L. The role of oxidative processes in emphysema. Am Rev Respir Dis. 127:1983;S31-S38.
56. Clark R.A., Stone P.J., El Hag A., Calore J.D., Franzblau C. Myeloperoxidase-catalyzed inactivation of alpha 1-protease inhibitor by human neutrophils. J Biol Chem. 256:1981;3348-3353.
57. Ward P.A., Johnson K.J., Till G.O. Complement and experimental respiratory failure. Intens Care Med. 12:1986;17-21.
58. Chabot F., Mitchell J.A., Gutteridge J.M., Evans T.W. Reactive oxygen species in acute lung injury. Eur Respir J. 11:1998;745-757.
59. Bloomfield G.L., Holloway S., Ridings P.C., et al. Pretreatment with inhaled nitric oxide inhibits neutrophil migration and oxidative activity resulting in attenuated sepsis-induced acute lung injury. Crit Care Med. 25:1997;584-593.
60. Koyama S., Kobayashi T., Kubo K., Sekiguchi M., Ueda G. Recombinant-human superoxide dismutase attenuates endotoxin-induced lung injury in awake sheep. Am Rev Respir Dis. 145:1992;1404-1409.
61. Gonzalez P.K., Zhuang J., Doctrow S.R., et al. EUK-8, a synthetic superoxide dismutase, and catalase mimetic, ameliorates acute lung injury in endotoxemic swine. J Pharmacol Exp Ther. 275:1995;798-806.
62. Guice K.S., Oldham K.T., Caty M.G., Johnson K.J., Ward P.A. Neutrophil-dependent, oxygen-radical mediated lung injury associated with acute pancreatitis. Ann Surg. 210:1989;740-747.
63. Leff J.A., Baer J.W., Bodman M.E., et al. Interleukin-1-induced lung neutrophil accumulation, and oxygen metabolite-mediated lung leak in rats. Am J Physiol. 226:1994;L2-L8.
64. McCord J.M., Gao B., Leff J., Flores S.C. Neutrophil-generated free radicals possible mechanisms of injury in adult respiratory distress syndrome . Environ Health Perspect. 102:(suppl):1994;57-60.
65. Hammond B., Kontos H.A., Hess M.L. Oxygen radicals in the adult respiratory distress syndrome, in myocardial ischemia and reperfusion injury, and in cerebral vascular damage. Can J Physiol Pharmacol. 63:1985;173-187.
66. Till G.O., Johnson K.J., Kunkel R., Ward P.A. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J Clin Invest. 69:1982;1126-1135.
67. Kubo H., Morgenstern D., Quinlan W.M., Ward P.A., Dinauer M.C., Doerschuk C.M. Preservation of complement-induced lung injury in mice with deficiency of NADPH oxidase. J Clin Invest. 97:1996;2680-2684.
68. Morganroth M.L., Till G.O., Kunkel R.G., Ward P.A. Complement and neutrophil-mediated injury of perfused rat lungs. Lab Invest. 54:1986;507-514.
69. Tinsley C.H., Tinsley L.R., Nishida S.D., Premaratne S., McNamara J.J. Measurement of oxygen free radicals in a rabbit shock lung model. Effect of superoxide dismutase and retinol. Arch Surg. 131:1996;738-742.
70. Weiland J.E., Davis W.B., Holter J.F., Mohammed J.R., Dorinsky P.M., Gadek J.E. Lung neutrophil in the adult respiratory distress syndrome. Clinical and pathophysiologic significance. Am Rev Respir Dis. 133:1986;218-225.
71. Metnitz P.G., Bartens C., Fischer M., Fridrich P., Steltzer H., Druml W. Antioxidant status in patients with acute respiratory distress syndrome. Intens Care Med. 25:1999;180-185.
72. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem. 272:1997;20963-20966.
73. Goldstein J.L., Ho Y.K., Basu S.K., Brown M.S. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Cell Biol. 76:1979;333-337.
74. Cathcart M.K., Morel D.W., Chisolm G.M. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic. J Leukoc Biol. 38:1985;341-350.
75. Katsura M., Forster L.A., Ferns G.A.A., Änggård E.E. Oxidative modification of low-density lipoprotein by human polymorphonuclear leucocytes to a form recognised by the lipoprotein scavenger pathway. Biochim Biophys Acta Lipids Lipid Metab. 1213:1994;231-237.
76. Abdalla D.S.P., Costa-Rosa L.F.B.P., Monteiro H.P., Campa A., Curi R. Human macrophage metabolism of low density lipoprotein oxidized by stimulated neutrophils and ferritin. Atherosclerosis. 107:1994;157-163.
77. Wieland E., Brandes A., Armstrong V.W., Oellerich M. Oxidative modification of low density lipoprotein by human polymorphonuclear leukocytes. Eur J Clin Chem Clin Biochem. 31:1993;725-731.
78. Park J.L., Lucchesi B.R. Mechanisms of myocardial reperfusion injury. Ann Thorac Surg. 68:1999;1905-1912.
79. Liao F., Berliner J.A., Mehrabian M., et al. Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest. 87:1991;2253-2257.
80. Hansen P.R. Role of neutrophils in myocardial ischemia and reperfusion. Circulation. 91:1995;1872-1885.
81. Ambrosio G., Tritto I. Reperfusion injury experimental evidence and clinical implications . Am Heart J. 138:1999;69-75.
82. Bolli R., Jeroudi M.O., Patel B.S., et al. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci. 86:1989;4695-4699.
83. Villari B., Ambrosio G., Golino P., et al. The effects of calcium channel antagonist treatment and oxygen radical scavenging on infarct size and the no-reflow phenomenon in reperfused hearts. Am Heart J. 125:1993;11.
84. Jolly S.R., Kane W.J., Bailie M.B., Abrams G.D., Lucchesi B.R. Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res. 54:1984;277-285.
85. Uraizee A., Reimer K.A., Murry C.E. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs. Circulation. 73:1987;1237-1238.
86. Gallagher K.P., Buda A.J., Pace D. Failure of superoxide dismutase and catalase to alter size of infarction in conscious dogs after 3 hours of occlusion followed by reperfusion. Circulation. 73:1986;1065-1076.
87. Omar BA, Gad NM, Jordan MC, et al. Cardioprotection by Cu,Zn-superoxide dismutase is lost at high doses in the reoxygenated heart. b)The cardioprotective effect of Mn-superoxide dismutase is lost at high doses in the postischemic isolated rabbit heart. Free Radic Biol Med. 1990;9:465-471,473-478.
88. McCord J.M. Oxygen-derived free radicals in postischemic tissue injury. NEJM. 312:1985;159-163.
89. Ambrosio G., Weisman H.F., Mannisi J.A., Becker L.C. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation. 80:1989;1846-1861.
90. Lefer A.M. Role of selectins in myocardial ischemia-reperfusion injury. Ann Thorac Surg. 60:1995;773-777.
91. 2-integrins and immunoglobulin superfamily members in myocardial ischemia-reperfusion. Ann Thorac Surg. 68:1999;1920-1923.
92. Shacter E., Beecham E.J., Covey J.M., Kohn K.W., Potter M. Activated neutrophils induce prolonged DNA damage in neighboring cells. Carcinogenesis. 9:1988;2297-2304.
93. Jackson J.H., Gajewski E., Schraufstaetter I.U., et al. Damage to the bases in DNA induced by stimulated human neutrophils. J Clin Invest. 84:1996;1644-1649.
94. Frenkel K., Chrzan K. Hydrogen peroxide formation and DNA base modification by tumor promoter-activated polymorphonuclear leukocytes. Carcinogenesis. 8:1987;455-460.
95. Weitzman S.A., Weitberg A.B., Clark E.P., Stossel T.P. Phagocytes as carcinogens malignant transformation produced by human neutrophils . Science. 227:1985;1231-1233.
96. Tamatani T., Turk P., Weitzman S., Oyasu R. Tumorigenic conversion of a rat urothelial cell line by human polymorphonuclear leukocytes activated by lipopolysaccharide. Jpn J Cancer Res. 90:1999;829-836.
97. Trush M.A., Seed J.L., Kensler T.W. Oxidant-dependent metabolic activation of polycyclic aromatic hydrocarbons by phorbol ester-stimulated human polymorphonuclear leukocytes possible link between inflammation and cancer . Proc Natl Acad Sci. 82:1985;5194-5199.
98. Shen J.H., Wegenke M., Wolff T. Capability of human blood cells to form the DNA adduct, C8-(N2-aminofluorenyl)-deoxyguanosine-3′-5′-diphosphate from 2-aminofluorene. Carcinogenesis. 11:1990;1441-1444.
99. Chapman M.L., Rubin B.R., Gracy R.W. Increased carbonyl content of proteins in synovial fluid from patients with rheumatoid arthritis. J Rheumatol. 16:1989;15-18.
100. Kaur H., Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotyrosine in serum and synovial fluid from rheumatoid patients. FEBS Lett. 350:1994;9-12.
101. Parizada B., Werber M.M., Nimrod A. Protective effects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis. Free Radic Res Commun. 15:1991;297-301.
102. Kakimoto K., Kojima Y., Ishii K., Onoue K., Maeda H. The suppressive effect of gelatin-conjugated superoxide dismutase on disease development and severity of collagen-induced arthritis in mice. Clin Exp Immunol. 94:1993;241-246.
103. Schmitz E., Ruschen S., Warnatz H. Superoxide anion production by monocytes and synovial fluid macrophages of patients with chronic inflammatory joint disorders. Z Rheumatol. 46:1987;227-232.
104. Dulray B., Elson C.J., Dieppe P.A. Enhanced oxidative response of polymorphonuclear leukocytes from synovial fluids of patients with rheumatoid arthritis. Autoimmunity. 1:1988;159-169.
105. Oishi S., Shingu M., Ezaki I., Nobunaga M., Sakai K. Rheumatoid factor modulation of neutrophil superoxide generation enhancing activity of preformed immune complexes. Rheumatol Int. 10:1990;9-12.
106. Dewar C.L., Harth M. Superoxide production from cytokine-treated adherent rheumatoid neutrophils. Clin Invest Med. 17:1994;52-60.
107. Robinson J.J., Watson F., Phelan M., Bucknall R.C., Edwards S.W. Activation of neutrophils by soluble and insoluble immunoglobulin aggregates from synovial fluid of patients with rheumatoid arthritis. Ann Rheum Dis. 52:1993;347-353.
108. Bender J.G., Van Epps D.E., Searles R., Williams R.C. Jr. Altered function of synovial fluid granulocytes in patients with acute inflammatory arthritis evidence for activation of neutrophils and its mediation by a factor present in synovial fluid . Inflammation. 10:1986;443-453.
109. Biemond P., Swaak A.J., Van Eijk H.G., Koster J.F. Intraarticular ferritin-bound iron in rheumatoid arthritis. A factor that increases oxygen free radical-induced tissue destruction. Arthritis Rheum. 29:1986;1187-1193.